Use of fty 720 and icam-1 antisense oligonucleotides for attenuating chronic renal damage secondary to ischemia-reperfusion injury

dc.date.accessioned2017-03-23T17:40:56Z
dc.date.available2017-03-23T17:40:56Z
dc.date.created2017-03-23T17:40:56Z
dc.date.issued2005
dc.identifier0041-1345
dc.identifierhttp://hdl.handle.net/10533/176633
dc.identifier1030385
dc.identifierWOS:000234412900034
dc.languageeng
dc.publisherELSEVIER SCIENCE INC.
dc.relationhttps://doi.org/10.1016/j.transproceed.2005.10.093
dc.relation10.1016/j.transproceed.2005.10.093
dc.relationinfo:eu-repo/grantAgreement/Fondecyt/1030385
dc.relationinfo:eu-repo/semantics/dataset/hdl.handle.net/10533/93477
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.relationinstname: Conicyt
dc.relationreponame: Repositorio Digital RI2.0
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleUse of fty 720 and icam-1 antisense oligonucleotides for attenuating chronic renal damage secondary to ischemia-reperfusion injury
dc.typeArticulo


Este ítem pertenece a la siguiente institución